What is NDC 24338-201?

24338-201 is the product NDC for Sutab, Sodium sulfate 17.75 g/1 + 2 more ingredients tablet, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Sutab (Sodium sulfate, magnesium sulfate, and potassium chloride).

What is the active ingredient?

Sodium sulfate, Magnesium sulfate anhydrous, Potassium chloride.

Azurity Pharmaceuticals, Inc., NDC labeler code 24338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sutab?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sutab NDC 24338-201 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)24338-201Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24338-0201Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24338-201-01	2433802010124338020101	2 BOTTLE, PLASTIC in 1 KIT (24338-201-01) / 12 TABLET in 1 BOTTLE, PLASTICMarketed from Apr 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sutab
Generic name (nonproprietary): sodium sulfate, magnesium sulfate, and potassium chloride
Active ingredients: Sodium sulfate — 17.75 g/1Magnesium sulfate anhydrous — 2.7 g/1Potassium chloride — 2.25 g/1
Dosage form: Tablet
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc.NDC labeler code 24338
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 213135
Marketing start: Apr 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 24338-201_c020e973-dccf-4862-999e-17db6209a48aSPL ID c020e973-dccf-4862-999e-17db6209a48aSPL set ID c020e973-dccf-4862-999e-17db6209a48aUNII 0YPR65R21J, ML30MJ2U7I, 660YQ98I10UPC 0324338202012
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424338020101 followed by a unit qualifier and the quantity

Package 24338-0201-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2026.

Indications (excerpt from the label)

SUTAB is indicated for the cleansing of the colon as a preparation for colonoscopy in adults. SUTAB is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 24338-201

What is NDC 24338-201?: 24338-201 is the product NDC for Sutab, Sodium sulfate 17.75 g/1 + 2 more ingredients tablet, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sutab (Sodium sulfate, magnesium sulfate, and potassium chloride).
What is the active ingredient?: Sodium sulfate, Magnesium sulfate anhydrous, Potassium chloride.
Who is the labeler?: Azurity Pharmaceuticals, Inc., NDC labeler code 24338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sutab?: 1 other product NDC are listed under this name. See all Sutab NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sutab NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sutabsodium sulfate, magnesium sulfate, and potassium chloride	Sodium sulfate 17.75 g/1 + 2 more ingredients	TabletOral	Braintree Laboratories, Inc.	52268-201	52268-0201-01

Other NDCs under NDA 213135

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 213135
Product	Strength	Form · route	Labeler	Product NDC
Sutabsodium sulfate, magnesium sulfate, and potassium chloride	Sodium sulfate 17.75 g/1 + 2 more ingredients	TabletOral	Braintree Laboratories, Inc.	52268-201